Jarosław Kępski/LinkedIn
Dec 13, 2025, 08:22
Jarosław Kępski: Managing Anticoagulation in Oncology Patients With Thrombocytopenia
Jarosław Kępski, Cardiologist and member of the ESC Council of Cardio-Oncology (COOL) Committee, reposted from Davood KHoda-Amorzideh on LinkedIn:
”Thrombocytopenia presents a particular challenge in oncology, especially when patients require anticoagulation. We invite you to read our analysis of current recommendations.”
Quoting Davood KHoda-Amorzideh‘s post:
”Anticoagulant – therapy in patients with cancer and thrombocytopenia.”
Title: Anticoagulant therapy in patients with cancer and thrombocytopenia
Author: Sebastian Szmit, Jarosław Kępski, Ewa Lech-Marańda, Dariusz M. Kowalski, Maciej Krzakowski, Magdalena Zaborowska-Szmit
Read the full article here.
Stay updated with Hemostasis Today.
-
Sep 24, 2026, 13:41Mahmoud Samir Bayomi: Raise ITP Awareness and Improve Patient Care
-
Sep 24, 2026, 12:56Maria Helena Parrinello: A New Score for Chronic GvHD Risk Assessment at the SIE Congress
-
Sep 24, 2026, 12:44Shehab Mohamed: TP53 Mutations and Outcomes in Myeloproliferative Neoplasms
-
Sep 24, 2026, 12:34Francesca Palandri: Is There Still a Place for Splenectomy in ITP in the Modern Era?
-
Sep 24, 2026, 12:15Cedric Hermans: RPTH Illustrated Review on Von Willebrand Disease
-
Sep 24, 2026, 11:48Factor XII Inhibition and the Future of Contact Pathway Targeting
-
Sep 24, 2026, 08:55Andres Gudino: Clot Characterization Through Hounsfield Units in Ischemic Stroke
-
Sep 24, 2026, 06:52Gina Sado: Screening-Detected Atrial Fibrillation Carries High Risk of Heart Failure
-
Sep 24, 2026, 06:33Benjamin Vipler: Optimal Oral Anticoagulation Choice in Atrial Fibrillation and Advanced CKD